599 filings
Page 9 of 30
6-K
2cuabxg
9 Nov 17
Report of Foreign Issuer
12:00am
6-K
rt3amg 5p
9 Nov 17
Report of Foreign Issuer
12:00am
6-K
87z cfzeud4
25 Aug 17
Consolidated Interim Financial Statements
12:00am
6-K
952 gmuh6wb
12 Jul 17
Portage Announces Results of Shareholders Meeting and Provides Update on Its Portfolio Companies
12:00am
6-K
667330rd 8rjz
17 May 17
Biohaven Announces Closing of Initial Public Offering and Full Exercise of Underwriters? Option to Purchase Additional Shares
12:00am
6-K
t2vznloxn9yj2
10 May 17
Portage?s Holding In Biohaven
12:00am
6-K
3s0vad6xz q8u
8 May 17
Biohaven Announces Pricing of Its Initial Public Offering of Common Shares
12:00am
3
k9y2qlo80s6f zbv
3 May 17
Initial statement of insider ownership
12:00am
6-K
cslk7 o4udx
12 Apr 17
Portage Provides Update on Its Portfolio Companies
12:00am
6-K
mamll7a2
10 Apr 17
Biohaven Files Registration Statement for Proposed Public Offering of Its Common Shares
12:00am
S-8
jwwc1bbbrs3xeg3
20 Mar 17
Registration of securities for employees
12:00am
6-K
ud7g2hgvt pnb7u
14 Mar 17
Biohaven Closes Second Tranche of Private Placement and Appoints Two New Directors to Board
12:00am
6-K
b9fe7vjio
27 Feb 17
Consolidated Interim Financial Statements
12:00am
6-K
mw6g8kxcn0pmsaa 9r
9 Dec 16
Biohaven? BHV-0223 Is Granted Orphan Drug Designation In the Treatment of Amyotrophic Lateral Sclerosis
12:00am
6-K
o5j889dy8bokj7icv15x
30 Nov 16
Portage Announces Spin-out of Eygen Limited
12:00am
6-K
s7vu4c12qf8lyf4t2
28 Nov 16
Interim Financials for the Three and Six Months Ended September 30, 2016
12:00am
6-K
s9v1d08ksy2se79u n50
3 Nov 16
Biohaven Raises $80 Million
12:00am
6-K
bat0dltgcv
21 Sep 16
Chairman's Letter to Shareholders
12:00am
6-K
timx8a89 rg1x
30 Aug 16
Consolidated Interim Financials for the Three Months Ended June 30, 2016 and Management Discussion and Analysis for the Same Period
12:00am